Just looked at Mindmed . It has a market cap of $1.7 billion and no revenues and in the process of raising $80 million for research and development. MindMed is psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and experiential therapies to address addiction and mental illness. No revenues any time soon. Holl have excellent
...more